Organization: Health Canada
Year: 2024
Month: June
Request Number: A-2023-001447
Request Summary: The most current status of the Abbreviated New Drug Submission (ANDS) seeking approval of a product containing the medicinal ingredient desmopressin acetate, which was accepted into review on or after March 1, 2022 but before December 1, 2022, and which received a letter/notice from Health Canada on November 2, 2022.
Disposition: Disclosed in part
Number of pages: 1